LIFEVANTAGE CORP Cost of Revenue
LIFEVANTAGE CORP (LFVN) reported Cost of Revenue of $40.97 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-27
- LIFEVANTAGE CORP cost of goods and services sold for the quarter ending 2026-06-30 was $9.33M, a 15.64% decline year-over-year.
- LIFEVANTAGE CORP cost of goods and services sold for the quarter ending 2026-03-31 was $9.17M, a 17.47% decline year-over-year.
- LIFEVANTAGE CORP cost of goods and services sold for the quarter ending 2025-12-31 was $12.72M, a 3.58% decline year-over-year.
- LIFEVANTAGE CORP cost of goods and services sold for the quarter ending 2025-09-30 was $9.74M, a 2.68% increase year-over-year.
- LIFEVANTAGE CORP cost of goods and services sold for fiscal 2026 was $40.97M, a 8.67% decline from fiscal 2025.
- LIFEVANTAGE CORP cost of goods and services sold for fiscal 2025 was $44.86M, a 8.26% increase from fiscal 2024.
- LIFEVANTAGE CORP cost of goods and services sold for fiscal 2024 was $41.44M, a 4.49% decline from fiscal 2023.
- LIFEVANTAGE CORP cost of goods and services sold for fiscal 2023 was $43.39M, a 13.89% increase from fiscal 2022.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $9.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $18.51M derived: sum of 2 quarters · filed 2026-08-27 | $31.23M derived: sum of 3 quarters · filed 2026-08-27 | $40.97M 10-K · filed 2026-08-27 | ||||
| 2026-03-31 | $9.17M 10-Q · filed 2026-05-06 | $21.89M derived: sum of 2 quarters · filed 2026-05-06 | $31.64M 10-Q · filed 2026-05-06 | $42.70M derived: sum of 4 quarters · filed 2026-08-27 | ||||
| 2025-12-31 | $12.72M 10-Q · filed 2026-02-04 | $22.47M 10-Q · filed 2026-02-04 | $33.53M derived: sum of 3 quarters · filed 2026-08-27 | $44.65M derived: sum of 4 quarters · filed 2026-08-27 | ||||
| 2025-09-30 | $9.74M 10-Q · filed 2025-11-04 | $20.81M derived: sum of 2 quarters · filed 2026-08-27 | $31.92M derived: sum of 3 quarters · filed 2026-08-27 | $45.12M derived: sum of 4 quarters · filed 2026-08-27 | ||||
| 2025-06-30 | $11.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $22.18M derived: sum of 2 quarters · filed 2026-08-27 | $35.37M derived: sum of 3 quarters · filed 2026-08-27 | $44.86M 10-K · filed 2026-08-27 | ||||
| 2025-03-31 | $11.11M 10-Q · filed 2026-05-06 | $24.31M derived: sum of 2 quarters · filed 2026-05-06 | $33.80M 10-Q · filed 2026-05-06 | $43.82M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $13.20M 10-Q · filed 2026-02-04 | $22.69M 10-Q · filed 2026-02-04 | $32.71M derived: sum of 3 quarters · filed 2026-02-04 | $42.88M derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2024-09-30 | $9.49M 10-Q · filed 2025-11-04 | $19.51M derived: sum of 2 quarters · filed 2025-11-04 | $29.68M derived: sum of 3 quarters · filed 2025-11-04 | $40.75M derived: sum of 4 quarters · filed 2025-11-04 | ||||
| 2024-06-30 | $10.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-04 | $20.19M derived: sum of 2 quarters · filed 2025-09-04 | $31.26M derived: sum of 3 quarters · filed 2025-09-04 | $41.44M 10-K · filed 2025-09-04 | ||||
| 2024-03-31 | $10.17M 10-Q · filed 2025-05-06 | $21.24M derived: sum of 2 quarters · filed 2025-05-06 | $31.42M 10-Q · filed 2025-05-06 | $42.49M derived: sum of 4 quarters · filed 2025-05-06 | ||||
| 2023-12-31 | $11.07M 10-Q · filed 2025-02-05 | $21.25M 10-Q · filed 2025-02-05 | $32.31M derived: sum of 3 quarters · filed 2025-02-05 | $42.93M derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2023-09-30 | $10.18M 10-Q · filed 2024-10-29 | $21.25M derived: sum of 2 quarters · filed 2024-10-29 | $31.87M derived: sum of 3 quarters · filed 2024-10-29 | $43.63M derived: sum of 4 quarters · filed 2024-10-29 | ||||
| 2023-06-30 | $11.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | $21.69M derived: sum of 2 quarters · filed 2024-08-28 | $33.45M derived: sum of 3 quarters · filed 2024-08-28 | $43.39M 10-K · filed 2024-08-28 | ||||
| 2023-03-31 | $10.62M 10-Q · filed 2024-05-02 | $22.38M derived: sum of 2 quarters · filed 2024-05-02 | $32.32M 10-Q · filed 2024-05-02 | $41.65M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2022-12-31 | $11.76M 10-Q · filed 2024-01-30 | $21.70M 10-Q · filed 2024-01-30 | $31.03M derived: sum of 3 quarters · filed 2024-01-30 | $40.69M derived: sum of 4 quarters · filed 2024-01-30 | ||||
| 2022-09-30 | $9.94M 10-Q · filed 2023-11-09 | $19.27M derived: sum of 2 quarters · filed 2023-11-09 | $28.93M derived: sum of 3 quarters · filed 2023-11-09 | $38.61M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $9.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-28 | $18.99M derived: sum of 2 quarters · filed 2023-08-28 | $28.67M derived: sum of 3 quarters · filed 2023-08-28 | $38.10M 10-K · filed 2023-08-28 | ||||
| 2022-03-31 | $9.66M 10-Q · filed 2023-05-04 | $19.33M derived: sum of 2 quarters · filed 2023-05-04 | $28.77M 10-Q · filed 2023-05-04 | $38.55M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $9.68M 10-Q · filed 2023-02-02 | $19.11M 10-Q · filed 2023-02-02 | $28.89M derived: sum of 3 quarters · filed 2023-02-02 | $37.71M derived: sum of 4 quarters · filed 2023-02-02 | ||||
| 2021-09-30 | $9.43M 10-Q · filed 2022-11-02 | $19.21M derived: sum of 2 quarters · filed 2022-11-02 | $28.03M derived: sum of 3 quarters · filed 2022-11-02 | $38.22M derived: sum of 4 quarters · filed 2022-11-02 | ||||
| 2021-06-30 | $9.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-23 | $18.60M derived: sum of 2 quarters · filed 2022-08-23 | $28.79M derived: sum of 3 quarters · filed 2022-08-23 | $38.19M 10-K · filed 2022-08-23 | ||||
| 2021-03-31 | $8.82M 10-Q · filed 2022-05-03 | $19.01M derived: sum of 2 quarters · filed 2022-05-03 | $28.40M 10-Q · filed 2022-05-03 | $37.85M derived: sum of 4 quarters · filed 2022-08-23 | ||||
| 2020-12-31 | $10.19M 10-Q · filed 2022-02-01 | $19.59M 10-Q · filed 2022-02-01 | $29.04M derived: sum of 3 quarters · filed 2022-08-23 | $38.13M derived: sum of 4 quarters · filed 2022-08-23 | ||||
| 2020-09-30 | $9.40M 10-Q · filed 2021-11-04 | $18.85M derived: sum of 2 quarters · filed 2022-08-23 | $27.94M derived: sum of 3 quarters · filed 2022-08-23 | $38.17M derived: sum of 4 quarters · filed 2022-08-23 | ||||
| 2020-06-30 | $9.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-23 | $18.54M derived: sum of 2 quarters · filed 2022-08-23 | $28.77M derived: sum of 3 quarters · filed 2022-08-23 | $37.96M 10-K · filed 2022-08-23 | ||||
| 2020-03-31 | $9.10M 10-Q · filed 2021-04-29 | $19.32M derived: sum of 2 quarters · filed 2021-04-29 | $28.52M 10-Q · filed 2021-04-29 | $38.23M derived: sum of 4 quarters · filed 2021-08-19 | ||||
| 2019-12-31 | $10.23M 10-Q · filed 2021-02-02 | $19.42M 10-Q · filed 2021-02-02 | $29.13M derived: sum of 3 quarters · filed 2021-08-19 | $38.40M derived: sum of 4 quarters · filed 2021-08-19 | ||||
| 2019-09-30 | $9.19M 10-Q · filed 2020-11-03 | $18.90M derived: sum of 2 quarters · filed 2021-08-19 | $28.17M derived: sum of 3 quarters · filed 2021-08-19 | $37.96M derived: sum of 4 quarters · filed 2021-08-19 | ||||
| 2019-06-30 | $9.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-19 | $18.98M derived: sum of 2 quarters · filed 2021-08-19 | $28.77M derived: sum of 3 quarters · filed 2021-08-19 | $37.97M 10-K · filed 2021-08-19 | ||||
| 2019-03-31 | $9.27M 10-Q · filed 2020-05-05 | $19.06M derived: sum of 2 quarters · filed 2020-05-05 | $28.26M 10-Q · filed 2020-05-05 | $36.33M derived: sum of 4 quarters · filed 2020-08-18 | ||||
| 2018-12-31 | $9.79M 10-Q · filed 2020-01-28 | $18.99M 10-Q · filed 2020-01-28 | $27.06M derived: sum of 3 quarters · filed 2020-08-18 | $35.98M derived: sum of 4 quarters · filed 2020-08-18 | ||||
| 2018-09-30 | $9.20M 10-Q · filed 2019-10-30 | $17.27M derived: sum of 2 quarters · filed 2020-08-18 | $26.19M derived: sum of 3 quarters · filed 2020-08-18 | $35.31M derived: sum of 4 quarters · filed 2020-08-18 | ||||
| 2018-06-30 | $8.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-18 | $16.99M derived: sum of 2 quarters · filed 2020-08-18 | $26.11M derived: sum of 3 quarters · filed 2020-08-18 | $34.85M 10-K · filed 2020-08-18 | ||||
| 2018-03-31 | $8.92M 10-Q · filed 2019-05-01 | $18.04M derived: sum of 2 quarters · filed 2019-05-01 | $26.78M 10-Q · filed 2019-05-01 | $35.67M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2017-12-31 | $9.12M 10-Q · filed 2019-02-04 | $17.86M 10-Q · filed 2019-02-04 | $26.75M derived: sum of 3 quarters · filed 2019-08-14 | $34.98M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2017-09-30 | $8.74M 10-Q · filed 2018-11-01 | $17.63M derived: sum of 2 quarters · filed 2019-08-14 | $25.86M derived: sum of 3 quarters · filed 2019-08-14 | $33.36M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2017-06-30 | $8.89M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-14 | $17.12M derived: sum of 2 quarters · filed 2019-08-14 | $24.62M derived: sum of 3 quarters · filed 2019-08-14 | $33.46M 10-K · filed 2019-08-14 | ||||
| 2017-03-31 | $8.23M 10-Q · filed 2018-05-09 | $15.73M derived: sum of 2 quarters · filed 2018-05-09 | $24.57M 10-Q · filed 2018-05-09 | $33.97M derived: sum of 4 quarters · filed 2018-08-15 | ||||
| 2016-12-31 | $7.50M 10-Q · filed 2018-02-07 | $16.33M 10-Q · filed 2018-02-07 | $25.73M derived: sum of 3 quarters · filed 2018-08-15 | $35.45M derived: sum of 4 quarters · filed 2018-08-15 | ||||
| 2016-09-30 | $8.83M 10-Q · filed 2017-11-08 | $18.23M derived: sum of 2 quarters · filed 2018-08-15 | $27.95M derived: sum of 3 quarters · filed 2018-08-15 | $35.79M derived: sum of 4 quarters · filed 2018-08-15 | ||||
| 2016-06-30 | $9.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-15 | $19.11M derived: sum of 2 quarters · filed 2018-08-15 | $26.96M derived: sum of 3 quarters · filed 2018-08-15 | $33.93M 10-K · filed 2018-08-15 | ||||
| 2016-03-31 | $9.71M 10-Q · filed 2017-05-10 | $17.56M derived: sum of 2 quarters · filed 2017-05-10 | $24.53M 10-Q · filed 2017-05-10 | $31.82M derived: sum of 4 quarters · filed 2017-09-07 | ||||
| 2015-12-31 | $7.84M 10-Q · filed 2017-02-08 | $14.82M 10-Q · filed 2017-02-08 | $22.11M derived: sum of 3 quarters · filed 2017-09-07 | $29.66M derived: sum of 4 quarters · filed 2017-09-07 | ||||
| 2015-09-30 | $6.97M 10-Q · filed 2016-12-12 | $14.27M derived: sum of 2 quarters · filed 2017-09-07 | $21.82M derived: sum of 3 quarters · filed 2017-09-07 | $29.31M derived: sum of 4 quarters · filed 2017-09-07 | ||||
| 2015-06-30 | $7.29M derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-09-07 | $14.85M derived: sum of 2 quarters · filed 2017-09-07 | $22.33M derived: sum of 3 quarters · filed 2017-09-07 | $28.01M 10-K · filed 2017-09-07 | ||||
| 2015-03-31 | $7.55M 10-Q/A · filed 2016-07-19 | $15.04M derived: sum of 2 quarters · filed 2016-07-19 | $20.72M 10-Q/A · filed 2016-07-19 | $29.70M derived: sum of 4 quarters · filed 2016-12-12 | ||||
| 2014-12-31 | $7.49M 10-Q · filed 2016-02-09 | $13.16M 10-Q · filed 2016-02-09 | $22.15M derived: sum of 3 quarters · filed 2016-12-12 | $30.61M derived: sum of 4 quarters · filed 2016-12-12 | ||||
| 2014-09-30 | $5.68M 10-Q · filed 2015-11-04 | $14.66M derived: sum of 2 quarters · filed 2016-12-12 | $23.12M derived: sum of 3 quarters · filed 2016-12-12 | $31.06M derived: sum of 4 quarters · filed 2016-12-12 | ||||
| 2014-06-30 | $8.98M derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-12 | $17.44M derived: sum of 2 quarters · filed 2016-12-12 | $25.39M derived: sum of 3 quarters · filed 2016-12-12 | $33.19M 10-K · filed 2016-12-12 | ||||
| 2014-03-31 | $8.46M 10-Q · filed 2015-05-06 | $16.40M derived: sum of 2 quarters · filed 2015-05-06 | $24.21M 10-Q · filed 2015-05-06 | $32.12M derived: sum of 4 quarters · filed 2015-09-01 | ||||
| 2013-12-31 | $7.94M 10-Q · filed 2015-02-04 | $15.75M 10-Q · filed 2015-02-04 | $23.66M derived: sum of 3 quarters · filed 2015-09-01 | $30.99M derived: sum of 4 quarters · filed 2015-09-01 | ||||
| 2013-09-30 | $7.81M 10-Q · filed 2014-11-06 | $15.72M derived: sum of 2 quarters · filed 2015-09-01 | $23.05M derived: sum of 3 quarters · filed 2015-09-01 | $31.85M derived: sum of 4 quarters · filed 2015-09-01 | ||||
| 2013-06-30 | $7.91M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-01 | $15.24M derived: sum of 2 quarters · filed 2015-09-01 | $24.04M derived: sum of 3 quarters · filed 2015-09-01 | $31.84M 10-K · filed 2015-09-01 | ||||
| 2013-03-31 | $7.33M 10-Q · filed 2014-05-06 | $16.13M derived: sum of 2 quarters · filed 2014-05-06 | $23.94M 10-Q · filed 2014-05-06 | $30.36M derived: sum of 4 quarters · filed 2014-09-10 | ||||
| 2012-12-31 | $8.80M 10-Q · filed 2014-02-06 | $16.61M 10-Q · filed 2014-02-06 | $23.03M derived: sum of 3 quarters · filed 2014-09-10 | $28.02M derived: sum of 4 quarters · filed 2014-09-10 | ||||
| 2012-09-30 | $7.81M 10-Q · filed 2013-11-07 | $14.23M derived: sum of 2 quarters · filed 2014-09-10 | $19.22M derived: sum of 3 quarters · filed 2014-09-10 | $22.90M derived: sum of 4 quarters · filed 2014-09-10 | ||||
| 2012-06-30 | $6.43M derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-10 | $11.42M derived: sum of 2 quarters · filed 2014-09-10 | $15.10M derived: sum of 3 quarters · filed 2014-09-10 | $18.05M 10-K · filed 2014-09-10 | $18.05M 10-K · filed 2012-09-10 | |||
| 2012-03-31 | $4.99M 10-Q · filed 2013-05-09 | $4.99M 10-Q · filed 2012-05-15 | $8.67M derived: sum of 2 quarters · filed 2013-05-09 | $11.63M 10-Q · filed 2013-05-09 | $11.62M 10-Q · filed 2012-05-15 | $13.75M derived: sum of 4 quarters · filed 2013-09-12 | ||
| 2011-12-31 | $3.68M 10-Q · filed 2013-02-07 | $3.68M 10-Q · filed 2012-02-14 | $6.64M 10-Q · filed 2013-02-07 | $6.64M 10-Q · filed 2012-02-14 | $8.76M derived: sum of 3 quarters · filed 2013-09-12 | $10.34M derived: sum of 4 quarters · filed 2013-09-12 | ||
| 2011-09-30 | $2.96M 10-Q · filed 2012-11-08 | $2.96M 10-Q · filed 2011-11-14 | $5.08M derived: sum of 2 quarters · filed 2013-09-12 | $6.66M derived: sum of 3 quarters · filed 2013-09-12 | $7.85M derived: sum of 4 quarters · filed 2013-09-12 | |||
| 2011-06-30 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-12 | $3.71M derived: sum of 2 quarters · filed 2013-09-12 | $4.90M derived: sum of 3 quarters · filed 2013-09-12 | $5.92M 10-K · filed 2013-09-12 | $5.92M 10-K · filed 2012-09-10 | |||
| 2011-03-31 | $1.58M 10-Q · filed 2012-05-15 | $2.77M derived: sum of 2 quarters · filed 2012-05-15 | $3.79M 10-Q · filed 2012-05-15 | |||||
| 2010-12-31 | $1.19M 10-Q · filed 2012-02-14 | $2.21M 10-Q · filed 2012-02-14 | ||||||
| 2010-09-30 | $1.02M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |